CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to...
SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to...
Florida, US, 30th January 2026, ZEX PR WIRE, Most students don’t spend the start of summer walking...
Jon DiPietra, a New York–based real estate valuation executive, explains why common beliefs about space...
San Diego, California, 30th January 2026, ZEX PR WIRE, Roger Haenke has spent his career at the...
Tabber Benedict of New York urges founders, investors, and business owners to adopt clearer communication...
Dubai, UAE, 30th January 2026, ZEX PR WIRE, Synapse Power today announced the official mainnet launch of XNAP,...
Empowering creators with data-driven exposure, licensing, and global audience tools. At Artramedia, we believe that...
Nashville, TN, 30th January 2026, ZEX PR WIRE, After one of the most devastating winter events in...
West Hempstead, New York, 30th January 2026, ZEX PR WIRE, Healthcare executive and consultant Wendy Gregg, MSW, MBA,...
Melbourne, Victoria, 29th January 2026, ZEX PR WIRE, RV Advisory Group Pty Ltd, an Australian accounting...